ABSTRACT
INTRODUCTION
In patients with chronic obstructive pulmonary disease (COPD), health-related quality of life (HRQoL) is significantly reduced compared with healthy individuals 1 and better HRQoL has been related to reduced hospital admissions. 2 Pulmonary rehabilitation (PR) has been shown to
SUMMARY AT A GLANCE
Ongoing feedback (telephone calls and biofeedback) was no more effective than no feedback during a 12-month unsupervised walking programme that followed a short-term supervised walking programme. Based on these findings, further research is needed to investigate the optimal design of unsupervised maintenance programmes in patients with COPD.
improve HRQoL 3 as well as improve exercise capacity and reduce hospital admissions in patients with COPD. [4] [5] [6] Following completion of short-term (6-12 weeks) PR programmes, the positive effects on HRQoL and exercise capacity 3 have been shown to decline within 1-2 years. [7] [8] [9] Maintenance exercise programmes aim to encourage long-term adherence to exercise in order to preserve the benefits achieved during short-term programmes. While a recent systematic review concluded that maintenance programmes with supervised exercise sessions, conducted at least once per week can maintain exercise capacity for up to 6 months in patients with COPD, 10 many PR programmes lack the capacity to offer long-term supervised maintenance exercise programmes. [11] [12] [13] Randomized controlled trials (RCT) investigating unsupervised maintenance programmes have shown little effect on maintaining HRQoL and exercise capacity, despite using strategies to encourage adherence such as telephone support with or without monthly supervised exercise sessions. 7, 14, 15 When biofeedback strategies have been added to telephone support, maintenance of effects has been shown. 16, 17 However, these previous findings should be interpreted with caution due to limitations arising from very small sample size 17 and short durations of follow-up. 16, 17 As such, the effectiveness of telephone support combined with biofeedback to maintain HRQoL and exercise capacity during an unsupervised maintenance walking programme over a longer time period remains unknown.
The primary aim of this study was to evaluate, in patients with COPD, the effect on HRQoL of adding ongoing feedback (telephone calls, biofeedback via pedometer and progressive goal setting) compared with no feedback during a 12-month unsupervised maintenance walking programme, which followed a supervised walking training programme. The hypothesis was that, at study completion, participants who received the ongoing feedback would have better HRQoL compared with those who did not receive the ongoing feedback. The secondary aim of the study was to evaluate the effects of the ongoing feedback on exercise capacity and adherence to the maintenance walking programme.
METHODS
The study was a long-term, prospective, assessorblinded, multicentre (five sites), RCT with concealed allocation. Participants were randomized prior to commencing a 2-month supervised walking training programme (i.e. baseline) via an independent telephone randomization service using computerized random number generator sequencing into two groups: an intervention group (IG) and a control group (CG). Before commencing the 12-month maintenance programme, both groups received the same 2-month intervention of a supervised, walking training programme, two to three times per week. The findings of the 2-month study have been previously reported, comparing the effects of supervised walking training (combined IG and CG) to a group who received usual medical care and did not participate in any exercise training. 18 The intervention for participants in the IG and CG only differed once they entered the 12-month maintenance phase. Randomization was stratified according to lung function (forced expiratory volume in 1 s (FEV 1 ) < or ≥40% predicted), HRQoL measures using the St George's Respiratory Questionnaire (SGRQ) (total score < or ≥45), exercise capacity (6-min walk distance (6MWD) < or ≥70% predicted) and trial centre.
Participants were recruited from outpatient PR programmes in two cities within Australia between May 2009 and June 2012. Inclusion and exclusion criteria have been previously described. 18 Written informed consent was obtained from all participants. The study was approved by the ethics committees of Sydney South West Area Health Service (Sydney, Australia), The University of Sydney (Sydney, Australia), Curtin University (Perth, Australia), Sir Charles Gairdner Hospital (Nedlands, Australia) and Bentley Hospital (Perth, Australia) .
Following completion of the short-term supervised programme, both the IG and CG were instructed to perform unsupervised maintenance walking exercise, 3 days a week for 12 months starting at the same duration achieved in the final week of supervised training and at a pace which elicited a dyspnoea score of three to four on a modified 0-10 point category-ratio dyspnoea scale. 19 In addition, the IG received telephone calls, biofeedback provided via a pedometer (G-Sensor accelerometer, Pedometers Australia, Cannington, Australia) and progressive goal setting (based on pedometer data). Diaries were provided for participants in both groups to record details of completed walking sessions. Further details of the intervention and the telephone script can be found in Appendices S1 and S2 (Supplementary Information).
Assessment protocol and measurements
Participants were assessed on four occasions over a 14-month period as follows: (i) prior to commencing the 2-month supervised walking training programme (baseline assessment), (ii) at the end of the 2-month supervised walking training programme which marked the commencement of the maintenance phase (2-month assessment), (iii) after 6 months of maintenance (8-month assessment) and (iv) after 12 months of maintenance (14-month assessment). During the baseline assessment, age, height, weight, gender, co-morbid conditions and medication use were recorded. Levels of anxiety and depression were measured by the Hospital Anxiety and Depression Scale (HADS). 20 At all four assessment time points, participants completed measures of HRQoL, exercise capacity and spirometric lung function over two visits within a 7-day period. FEV 1 and forced vital capacity (FVC) were collected using a calibrated portable spirometer (EasyOne spirometer, ndd Medical Technologies Inc., Andover, MA, USA) according to standard procedures. Lung volumes (body plethysmography) and single-breath diffusing capacity of the lung for carbon monoxide (DL CO ) were measured at baseline only, according to standard protocols. Measures obtained were compared with normative data. [21] [22] [23] Disease severity was classified according to the Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease (GOLD) spirometric criteria.
Health-related quality of life
The primary outcome was HRQoL measured by the SGRQ. 25 The interviewer-administered Chronic Respiratory Disease Questionnaire (CRQ), with the individualized dyspnoea domain, was also completed. 26 
Exercise capacity
Functional exercise capacity was measured by the 6-min walk test (6MWT), peak exercise capacity by the incremental shuttle walk test (ISWT) and endurance exercise capacity by the endurance shuttle walk test (ESWT). 27 Procedures for the walk tests have been previously described. 18 Adherence to unsupervised maintenance walking programme Adherence in both groups was determined using data from diaries and also, for the IG, by reviewing telephone transcripts. At the 8-month and 14-month assessments, the number of returned diaries in both groups was recorded, as well as the number of completed telephone transcripts in the IG.
Sample size and data analysis
The sample size was based on detection of a clinical meaningful difference in total SGRQ score between the IG and CG at the 14-month assessment. Eighty-six participants were sufficient to provide 80% power to detect a between-group difference in SGRQ total score of at least 7.7 points, which is greater than the minimum clinically important difference (α = 0.05, two-sided). 28 This assumed an SD of 12.7 points in total SGRQ score as previously reported. 29 To allow for a 10% dropout, 95 participants were required. Data were analysed using SPSS software (Version 20 for Windows, IBM Inc, Armonk, NY, USA). Intention to treat analysis was conducted with no imputation of missing data. Descriptive statistics are presented as raw mean values and SD unless otherwise stated. Linear mixed models (LMM) were used to determine significance between groups across all time points using the sample that was available at each time point. An estimate of the within-group effect on three comparisons, baseline to 2 months; baseline to 14 months; and 2 to 14 months, was determined for each group using the least significant difference (pairwise comparison) and is reported as mean differences and 95% CI from the predicted values of the LMM. To evaluate the between-group treatment Withdrawn from study (3) DNA for assessment (3) Missing data: n = 5 DNA for assessment (5) Missing data: n = 4 DNA for assessment (4) Missing data: n = 9 Withdrawn from study (1) Deceased (1) DNA for assessment (7) 2 months supervised short-term walking training Start of maintenance study n = 41 8-month assessment n = 40 14-month assessment n = 39 8-month assessment n = 35 14-month assessment Missing data: n = 5 Withdrawn from study (2) DNA for assessment (3) Missing data: n = 8 Withdrawn from study (2) DNA for assessment (6) Figure 1 Participant flow. Numbers at each time point are based on those that entered the maintenance phase of the study. In some instances, participants may not have attended the 2-or 8-month assessment but attended the 14-month assessment. CG, control group; IG, intervention group. effect on these three comparisons, change scores were determined by simple subtraction of the within-group effect and differences in the change scores were compared using independent t-tests.
RESULTS
Participant flow is presented in Figure 1 . Baseline characteristics of participants were similar between groups (Table 1) . Participants had moderate to severe COPD (FEV 1 : 45 (15) % predicted), 24 reduced HRQoL (SGRQ total score: 46 (17)), reduced exercise capacity (6MWD: 74 (13) % predicted) and symptoms of anxiety and depression that were within normal range (0-7 points on HADS 20 ). Participants completed an average of 17 (7) out of a possible 24 supervised walking training sessions prior to commencement of the maintenance programme. Of the 95 participants who commenced the 2-month supervised walking training programme, 20 participants (21%) did not complete any of the 14-month outcome measures. No adverse events were reported during the study.
Health-related quality of life
The SGRQ outcomes are presented in Tables 2-4 and Figure 2A . Both the IG and CG significantly improved SGRQ total score at the end of the 2-month supervised walking training programme. Between-group analyses demonstrated no significant differences in the change in SGRQ from baseline to 14 months or from 2 to 14 months (Fig. 2A) . The results from the CRQ are presented in Tables S1-S3 (Supplementary Information) .
Exercise capacity
The exercise capacity outcomes are presented in Tables 2-4 and Figure 2B . Both the IG and CG significantly improved exercise capacity measured by the ESWT with the IG also significantly improving on the ISWT and 6MWT at the end of the 2-month supervised walking programme. Between-group analyses demonstrated no significant differences in change in exercise capacity from baseline to 14 months or from 2 to 14 months.
Adherence to unsupervised maintenance walking programme
Reported levels of adherence to unsupervised maintenance walking exercise sessions are presented in Table S4 (Supplementary Information). Between-group analyses of adherence levels were not possible due to lack of data in the CG.
DISCUSSION
This large, multicentre, RCT was designed to determine the effects on HRQoL of adding ongoing feedback to a 12-month unsupervised maintenance walking programme that followed a 2-month, supervised, walking training programme in patients with COPD. Although the supervised programme produced significant improvements in HRQoL in both groups, when all assessment time points were considered, there were no significant between-group differences in the magnitude of change in HRQoL or in any of the secondary outcomes between baseline and 14 months or between 2 and 14 months.
Our finding of no between-group differences in HRQoL is consistent with a previous RCT that showed Diabetes, n (%) 1 (2) 3 (7) Asthma, n (%) 7 (14) 6 (13) Bronchiectasis, n (%) 1 (2) 0 (0) Other respiratory history, n (%) 4 (8) 5 (11) Cancer, n (%) 3 (6) 4 (9) Non-cardiac surgery, n (%) 5 (10) Feedback during maintenance exercise no difference between groups in the SGRQ during a 12-month unsupervised maintenance exercise programme despite the IG receiving monthly supervised sessions. 7 However, some evidence of the effectiveness of the ongoing feedback in the IG was demonstrated by SGRQ total score being maintained from 2 to 14 months and remaining significantly better than baseline in the IG by the end of the study. In contrast, in the CG, there was a significant decline in SGRQ total score from 2 to 14 months and this had returned to baseline levels by the end of the study.
The ESWT is an outcome which represents endurance walking capacity and is particularly sensitive to the effects of short-term training in COPD. 27 Both groups had significant improvements in ESWT time following the short-term training. In the IG, there was a non-significant decline in ESWT time from 2 to 14 months which remained significantly better at 14 months compared with baseline. In contrast, the CG had a significant decline in ESWT time from 2 to 14 months and this had returned to baseline levels by the end of the study, demonstrating no maintenance of endurance walking capacity in this group. There were, however, no between-group differences in ESWT time when changes from baseline to 14 months or 2 to 14 months were compared. This finding is in contrast to previous RCTs or studies that demonstrated maintenance of functional exercise capacity during unsupervised maintenance walking programmes that investigated a similar combination of telephone support with biofeedback. 16, 17 However, these previous studies were limited by lack of blinded assessment, 16 small sample size 17 and short follow-up periods of 3 16 and 6 17 months. In addition, participants in these previous studies 16, 17 were randomized following completion of short-term PR whereas in our study, randomization occurred at commencement of the supervised walking training. Participants who complete PR may be more IG  CG  IG  CG  IG  CG  IG  CG   SGRQ, n  49  46  43  37  41  38  38  33  Total score 46 (18) 47 (16) 40 (12) 42 (16) 40 (15) 45 (18) 40 (17) 47 (17) 0.71 Symptoms 57 (22) 55 (22) 49 (22) 52 (25) 48 (22) 54 (27) 48 (24) 52 (24) 0.66 Activity 62 (20) 66 (19) 57 (18) 61 (19) 61 (19) 63 (20) 60 (22) 66 (19) 0.53 Impacts 32 (17) 35 (19) 27 (13) 28 (16) 25 (15) 32 (18) 26 (16) Table 3 Health-related quality of life and exercise capacity within-group differences compliant with exercise and be more motivated to participate in long-term exercise training, which could have contributed to the positive effects on exercise capacity. 16, 17 We chose to randomize participants prior to commencing a short-term PR programme as this is more representative of the patient population and patient journey.
While HRQoL and ESWT were maintained in the IG, this did not translate into between-group differences which may have been a consequence of a number of factors, in particular, that the changes were small in relation to the variability in measurements. The small effect of the intervention may have resulted from the relatively poor adherence to the unsupervised walking programme, which was somewhat surprising as we hypothesized that the regular feedback and ongoing support using health coaching principles 30 would have resulted in improved adherence during the maintenance phase. It appears from our findings that this level of support was not sufficient or appropriately targeted to change exercise behaviour and encourage adherence in patients with COPD in order to maintain a significantly greater HRQoL and exercise capacity than those not receiving such interventions. Adherence remains difficult to objectively measure and hence selfreported diaries are often used; however, our results demonstrated limited engagement in the use of diaries. While adherence levels in the CG appeared to be higher than in the IG, this only reflected the low number of diaries returned in the CG rather than greater adherence. A greater amount of data was available on the level of adherence in the IG due to information collected during the regular telephone calls. The IG adherence of 52% to the prescribed walking exercise frequency during the maintenance phase was similar to that reported in other studies 7, 31, 32 and may be a more accurate reflection of adherence levels in patients with COPD than that collected via diaries. A further explanation for the lack of between-group difference may be that both groups were instructed to do walking exercise during the maintenance programme, thus potentially reducing the between-group differences. This contrasts with a previous maintenance study 17 in which the comparison group did not do maintenance exercise and the use of telephone calls and pedometers was effective at producing between-group differences in HRQoL at 6 months following completion of the initial training programme, mainly due to a decline in HRQoL in the CG. 17 A limitation of the study was the relatively large loss to follow-up (21%) during the maintenance phase which meant that the target of 86 participants completing the study was not reached. This dropout rate is consistent with other maintenance studies in COPD. 7, 15, 17, 33 A larger sample size would have been unlikely to change the between-group differences as the P-values were not close to being significant and the magnitude of the differences were less than the minimum clinically important differences so unlikely to be important. A second limitation of the study was that a per-protocol analysis was not possible as there were insufficient data to determine accurate adherence to the maintenance walking programme, due to the inadequacies of diary use. In future studies, more objective measures of adherence would help inform clinicians about the true effect of unsupervised maintenance interventions in adherent participants. Despite these limitations, the strength of this study was the robust methodological design using intention-to-treat analysis with participants recruited prior to short-term supervised exercise training, thus reflecting real-life clinical practice.
In conclusion, this study investigated the effects on HRQoL of adding ongoing feedback to a 12-month unsupervised maintenance walking programme that followed a 2-month supervised walking training programme in patients with COPD. There were no between-group differences in the magnitude of change in HRQoL from baseline to 14 months or from 2 to 14 months. Based on these findings, ongoing feedback was no more effective than no feedback in maintaining the gains of short-term supervised walking programme. As long-term supervised maintenance exercise programmes are not always an option following PR, further research is needed to investigate the optimal design of unsupervised maintenance programmes in patients with COPD. tion group.
Appendix S2 Telephone script. 
